Facts & Figures

Descriptor
Renovo is a biopharmaceutical product company and a leader in the discovery and development of drugs to reduce scarring, improve wound healing and enhance tissue regeneration.

History
Founded in 1998 Renovo commenced operations in October 2000 and floated on the main market of the London Stock Exchange in April 2006.

Founding team
Professor Mark Ferguson, CEO, and Dr Sharon O’Kane

Head Office
The Manchester Incubator Building
48 Grafton Street
Manchester, M13 9XX
United Kingdom

Telephone: +44 (0) 161 276 7100
Fax: +44 (0) 161 276 7200
E-mail: info@renovo.com

Employees:
Approx. 110

Lead Products:

Details of the products under development are listed in the relevant section of the website.